Massachusetts Institute Of Technology;The Board of Trustees of the Leland Stanford Junior University
发明人:
申请号:
EP19187839.6
公开号:
EP3646879A1
申请日:
2015.08.12
申请国别(地区):
EP
年份:
2020
代理人:
摘要:
The present invention provides a method of treating cancer with a combination of IL-2 and an integrin-binding-Fc fusion protein. The methods of the invention can be applied to a broad range of cancer types.